Nba Games Today
Featured
As a lifelong football fan and someone who’s spent more than a few frosty afternoons on the sidelines—both as a former university player and now as a season
Watching the beautiful game evolve over the years, one of the most thrilling aspects has always been spotting that next generation of talent, the youngsters
As a lifelong football fan and someone who has spent more hours than I care to admit analyzing the beautiful game, both on the pitch and on the screen, I’ve
Find out how lyophilization, long-acting injectables, and sequential delivery can substantially reduce waste and environmental impact.
Pharmaceutical companies that want to ‘move the needle’ on sustainability efforts can take a more proactive approach to reduce their footprints. Here’s why.
Windgap Medical offers drug delivery devices that simplify, auto-mate, and accelerate the administration of complex injectables.
Brent Buchine, Miriam Silton, Jameson Woods and Andrew Ryan explore how the combination of gas power and a side-by-side cartridge configuration increases the working viscosity range for the mixing and delivery of complex injectable formulations.
Windgap Medical Appoints Max Meehan as Director of Corporate Development and Strategy
The autoinjector platform company known for its wet-dry drug delivery technology expands the leadership team.
The autoinjector platform company known for its wet-dry drug delivery technology expands the leadership team.
The autoinjector platform company known for its wet-dry drug delivery technology deepens its leadership bench.
Brent Buchine considers a faster path to market for automated and easy-to-use reconstitution devices through simplification of the delivery systems.
Co-Founder Brent Buchine discusses the need for automated, easy-to-use reconstitution devices, especially in lyophilised medications, and introduces Windgap Medical’s technology platforms, which rise to the challenge.
Windgap Medical, Inc., a leading specialty pharmaceutical and drug delivery platform company, announced today that it has successfully completed its final close with over $39 million of Series B-1 equity financing, led by Taiwania Capital.
Under the grant, researchers from the University's Center for Drug Design, College of Pharmacy, and Massachusetts-based pharmaceutical company Windgap Medical are collaborating to design an autoinjector.
Windgap Medical, Inc. announced today that it has a strategic partnership with ALK-Abelló, A/S ("ALK") to commercialize the company's epinephrine autoinjector (EAI) for the treatment of anaphylactic shock.
Windgap Medical, Inc. announced today that it has finalized a deal to enable a strategic investment from Molex Ventures, LLC, a subsidiary of Koch Industries ("Molex Ventures").
Announces next round of Life Sciences Accelerator Loan Program
I remember a time not so long ago when seeing “Kosovo” listed among the international fixtures felt novel, almost surprising. For years, their footballing jo
Finding that sweet spot between hitting the books and hitting the court is the eternal challenge for any student-athlete, especially within the high-stakes e
Watching the Navy basketball program gear up for the 2024 season, I can’t help but draw a parallel to a piece of wisdom I once heard about another sport enti
Co-Founder Brent Buchine discusses the need for automated, easy-to-use reconstitution devices, especially in lyophilised medications, and introduces Windgap Medical’s technology platforms, which rise to the challenge.
